3,832 children diagnosed with leprosy as India targets interruption of transmission by 2027

Public Health & Social Sector · 4 October 2026 · Based on The Hindu (original report)

2-minute summary

India diagnosed 3,832 children with leprosy during the 2025-26 period, with 37 children already exhibiting Grade-2 disability (G2D) at the time of diagnosis. This child caseload is 91.6% higher than the National Leprosy Eradication Programme's (NLEP) target of 2,000 cases for the year. According to WHO data, India reported the world's largest number of new leprosy cases (91,783) and new child cases (3,832) in 2025, accounting for a major share of the global burden alongside Brazil and Indonesia. The presence of G2D among newly diagnosed children highlights persistent challenges of delayed detection and ongoing transmission, threatening India's stated target under the National Strategic Plan for Leprosy 2023-27 to interrupt transmission at the district level by 2027.

Why it's in the news

The release of the NLEP annual report and WHO global updates for 2025-26 revealing high child caseloads and Grade-2 disabilities has brought renewed attention to India's leprosy elimination roadmap and delayed case detection.

Facts to remember

• India recorded 3,832 new leprosy cases among children in the 2025-26 reporting period.
• The National Strategic Plan for Leprosy 2023-27 targets the interruption of transmission at the district level by 2027.
• India recorded a total of 91,783 new leprosy cases in 2025-26, maintaining the world's largest leprosy burden.
• The World Health Organization (WHO) considers new cases among children below 15 years as an indicator of recent transmission.
• Grade-2 disability (G2D) among newly diagnosed leprosy patients is a clinical indicator of delayed medical detection.

Background and context

Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by Mycobacterium leprae. Historically plagued by deep social stigma, severe deformities, and isolation, India launched the National Leprosy Control Programme in 1955 and subsequently the National Leprosy Eradication Programme (NLEP) in 1983. The introduction of Multi-Drug Therapy (MDT) by the WHO in the early 1980s dramatically reduced the global disease burden. India achieved the elimination of leprosy as a public health problem at the national level in 2005 (defined as a prevalence rate of less than 1 case per 10,000 population). However, localized transmission, social stigma preventing early reporting, and gaps in active household surveillance continue to challenge complete interruption of transmission, particularly among vulnerable pediatric populations.

Constitutional provisions

• Article 47 — Directs the State to regard the raising of the level of nutrition and the standard of living of its people and the improvement of public health as among its primary duties, providing constitutional backing for national health programmes like the NLEP.

Committees and reports

• National Leprosy Eradication Programme (NLEP) Annual Report — Provides official epidemiological data on annual new case detections, child caseloads, and Grade-2 disability rates across Indian districts.

Government schemes

• National Leprosy Eradication Programme (NLEP) — Centrally sponsored scheme focused on active case detection, contact tracing, multi-drug therapy distribution, and disability prevention to eliminate leprosy.

International organisations

• World Health Organization (WHO) — Monitors global leprosy elimination targets, provides epidemiological guidelines regarding child case indicators and Grade-2 disabilities, and compiles global disease statistics.

Mains practice: Examine the public health challenges in eliminating leprosy in India, with special reference to pediatric caseloads and delayed detection indicators.

Introduction

Leprosy, a chronic bacterial infection caused by Mycobacterium leprae, remains a major public health concern in India despite achieving national elimination status in 2005. Recent NLEP data for 2025-26 revealing 3,832 child cases—surpassing targets by 91.6%—underscores persistent epidemiological gaps in interrupting transmission.

Public Health and Epidemiological Dimensions

• Pediatric Transmission Indicators: According to WHO guidelines, new cases among children under 15 years serve as a direct epidemiological marker of active, ongoing community transmission.

• Delayed Detection and Disability: The detection of 37 children with Grade-2 Disability (G2D) at the time of diagnosis reflects prolonged delays in identification, contradicting the NLEP objective of zero disability among new child cases.

• High Absolute Burden: India accounts for the largest share of global cases (91,783 in 2025), driven by dense populations, high-endemic pockets, and hard-to-reach rural terrains.

Institutional and Governance Bottlenecks

• Surveillance Gaps: Primary healthcare infrastructure often lacks specialized dermatological screening at the grass-roots level, leading to missed early-stage patches.

• Social Stigma: Deep-rooted societal discrimination forces patients to hide symptoms, delaying voluntary reporting until nerve damage or visible deformities manifest.

Way Forward

• Intensified Active Surveillance: Scale up household contact tracing and regular physical screenings in high-endemic districts through frontline Accredited Social Health Activists (ASHAs).

• Integration with Primary Care: Train general practitioners at Ayushman Arogya Mandirs for early symptom recognition and free Multi-Drug Therapy (MDT) administration.

• Community Sensitization: Launch targeted behavior change communication campaigns to dismantle leprosy-related social stigmas and promote early reporting.

Conclusion

Achieving the National Strategic Plan target of interrupting leprosy transmission by 2027 requires moving beyond passive case management toward aggressive active surveillance, aligning with the constitutional mandate of public health under Article 47 and Sustainable Development Goal 3.

Prelims practice questions

Q1. Consider the following statements regarding leprosy and its surveillance in India: 1. Leprosy is a chronic bacterial infection primarily affecting the skin and peripheral nerves, caused by Mycobacterium leprae. 2. The World Health Organization (WHO) considers new leprosy cases diagnosed among children under 15 years as an indicator of recent transmission. 3. Grade-2 disability (G2D) at the time of diagnosis is officially recognized as an indicator of early medical intervention and prompt case detection. How many of the above statements are correct?

1. Only one
2. Only two
3. All three
4. None

Answer: B. Statement 1 is correct because leprosy is caused by Mycobacterium leprae affecting skin and peripheral nerves. Statement 2 is correct as the WHO uses pediatric cases as an indicator of active community transmission. Statement 3 is incorrect because Grade-2 disability at diagnosis signifies delayed detection and advanced disease progression, not early intervention.

Q2. Which of the following bodies compiles global leprosy statistics and provides international guidelines on disease elimination parameters such as Grade-2 disability rates?

1. Médecins Sans Frontières (MSF)
2. International Committee of the Red Cross (ICRC)
3. World Health Organization (WHO)
4. United Nations Children's Fund (UNICEF)

Answer: C. The World Health Organization (WHO) tracks global leprosy data, publishes annual updates, and sets epidemiological standards including definitions for Grade-2 disability and transmission interruption.

Q3. Consider the following statements with reference to the National Leprosy Eradication Programme (NLEP) in India: 1. The NLEP is implemented under the administrative purview of the Ministry of Health and Family Welfare. 2. The National Strategic Plan for Leprosy aims to interrupt transmission of the disease at the district level. Which of the statements given above is/are correct?

1. 1 only
2. 2 only
3. Both 1 and 2
4. Neither 1 nor 2

Answer: C. Statement 1 is correct because the NLEP is a central health programme managed by the Ministry of Health and Family Welfare. Statement 2 is also correct as the National Strategic Plan for Leprosy (2023-27) explicitly aims to interrupt leprosy transmission at the district level.

Revision flashcards

• What is the primary causative pathogen of leprosy (Hansen's disease)? Mycobacterium leprae, a chronic bacterial infection that primarily affects the skin and peripheral nerves.
• Which nodal ministry implements the National Leprosy Eradication Programme (NLEP) in India? The Ministry of Health and Family Welfare.
• What epidemiological significance does the detection of leprosy in children under 15 years hold according to the WHO in 2026? It serves as a key indicator of recent and ongoing disease transmission within the community.
• What does the presence of Grade-2 Disability (G2D) at the time of a leprosy diagnosis indicate? It indicates delayed medical detection and advanced disease progression prior to treatment.
• Why does social stigma remain a major hurdle in eliminating leprosy in India? Stigma and fear of discrimination force patients to conceal symptoms, resulting in delayed voluntary reporting and continued community transmission.